Who
Brad L. Tade
CFO and Treasurer
Company insider
Files Form 4 as: CFO and Treasurer, ADMA Biologics.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $317K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Jul 2024
- Last trade
- 19 Feb 2026
- Last filed
- 23 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Feb 2026filed 23 Feb 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $106K6,479 at $16.32 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $106K6,479 at $16.32 | filing |
| 24 Jul 2025filed 28 Jul 2025 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $123K7,123 at $17.31 | filing |
| 26 Jun 2025filed 30 Jun 2025 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $181K9,838 at $18.40 | filing |
| 26 Feb 2025filed 27 Feb 2025 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code F | $83K5,280 at $15.78 | filing |
| 19 Feb 2025filed 21 Feb 2025 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —93,023 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code A | —62,227 at $0.00 | filing |
| 22 Nov 2024filed 22 Nov 2024 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Sold | $317K15,000 at $21.15 | filing |
| 24 Jul 2024filed 26 Jul 2024 | ADMA ADMA Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —115,100 at $0.00 | filing |
| 24 Jul 2024filed 26 Jul 2024 | ADMA ADMA BiologicsBiotechnology | SEC FORM 4 Code A | —72,400 at $0.00 | filing |
News
Arcturus Therapeutics (NASDAQ:ARCT) & ADMA Biologics (NASDAQ:ADMA) Head-To-Head SurveyADMA · dailypolitical.com · 18 Oct 2026Analyzing Anika Therapeutics (NASDAQ:ANIK) & ADMA Biologics (NASDAQ:ADMA)ADMA · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Brad L. Tade; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.